DOSSIER · UPDATED 18 NOV 2025

Bolden Therapeutics

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke.

boldentherapeutics.com ↗Claim this profile

Founded: 2019
Headcount: 17
Open roles: 0
Last raised: Grant · $406K

SECTION I · THE BRIEF

Inside Bolden Therapeutics

Brief #95628Updated 18 NOV 2025PROVIDENCEMEDICAL ORGANIZATIONSGRANT

Employbl Dossier

Bolden Therapeutics

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke.

Founded: 2019
Headcount: 17
Open roles: 0
Last raised: Grant · $406K

Section II · Premium ProfileMembers only

01Engineering interview process at Bolden TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Bolden Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Johnny Page

OPEN ROLES

Hiring at Bolden Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $2,600,880